Astonea Labs Quarterly Results
Astonea Labs quarterly results. In 2026, Astonea Labs (ASTONEALAB) reported revenue ₹0 Cr and net profit ₹0 Cr. Check ASTONEALAB market value to track the company's total market size over time.
ASTONEALAB Quarterly Results — Revenue, Profit & EPS Highlights
Astonea Labs latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. For annual financials, live price and key ratios, visit Astonea Labs share price screener.
- Revenue of ₹148 Cr in March 2026 (+0.0% vs March 2026, +51.0% vs March 2025)
- Net Profit of ₹5 Cr in March 2026 (+0.0% vs March 2026, +0.0% vs March 2025)
- EBITDA of ₹14 Cr in March 2026 (+0.0% vs March 2026)
- Operating Margin of 9.0% in March 2026 (+0.0pp vs March 2026)
- Earnings Per Share of ₹4.49 in March 2026 (+0.0% vs March 2026)
Astonea Labs Quarterly Results — Revenue, EBITDA, Net Profit & EPS
ASTONEALAB quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.
| Metric | 2026 | March 2026 | March 2025 | QoQ | YoY |
|---|---|---|---|---|---|
| Revenue (₹ Cr) | 0 | 148 | 98 | - | - |
| Net Profit (₹ Cr) | 0 | 5 | 5 | - | - |
| EBITDA (₹ Cr) | 0 | 14 | 15 | - | - |
| EPS (₹) | 0.00 | 4.49 | 6.94 | - | - |
| Operating Margin (%) | 0.0% | 9.0% | 16.0% | - | - |
ASTONEALAB Share Price Trend — 1-Year Movement Across Quarterly Results
Astonea Labs 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Review ASTONEALAB P/E comparison to evaluate earnings-based valuation against sector peers.
Revenue Trend (₹ Cr)
Net Profit Trend (₹ Cr)
Operating Margin Trend (%)
ASTONEALAB vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap
Astonea Labs latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Mar 2026 |
₹421,995.00 Cr | 1758.0 | 15,018 | 2,710 | -5.6% | - | 18.0% | 155.6 |
|
Divis Laboratories
Mar 2026 |
₹241,231.30 Cr | 9162.0 | 2,986 | 751 | -5.0% | - | 25.2% | 323.6 |
|
Torrent Pharmaceuti…
Mar 2026 |
₹188,719.51 Cr | 4615.3 | 4,111 | 364 | +27.7% | +42.2% | 8.9% | 401.0 |
|
Laurus Labs
Mar 2026 |
₹111,790.60 Cr | 2002.5 | 1,823 | 282 | -10.5% | - | 15.5% | 387.3 |
|
Zydus Life Science
Mar 2026 |
₹111,111.95 Cr | 1135.0 | 7,569 | 1,341 | -4.3% | - | 17.7% | 89.7 |
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores